Clinical Trial Update: Growth Hormone Treatment in Short Children Born Small for Gestational Age [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating growth hormone treatment in children born small for gestational age has completed, assessing its effects on height in short stature.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature
• Small For Gestational Age

Drugs mentioned

• HUMATROPE (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Infant, Small for Gestational Age | Phase 3 | Status: COMPLETED